News & Updates

Show Multimedia Only
JAK inhibitors shown safe, effective in RA patients

JAK inhibitors shown safe, effective in RA patients

11 Dec 2023

A recent study has demonstrated the safety and efficacy of oral Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) in the real-world setting, particularly in those who do not present with cardiovascular risk factors at baseline.

11 Dec 2023
One in six CYPs in SG develop long COVID One in six CYPs in SG develop long COVID

One in six CYPs in SG develop long COVID

11 Dec 2023 byAudrey Abella

In Singapore, about one in six children and young persons (CYPs) developed long COVID, with persistence of ≥1 symptoms 3 months after an acute COVID-19 infection, a survey study suggests.

11 Dec 2023
Myeloma patients may benefit from mezigdomide-dexamethasone doublet

Myeloma patients may benefit from mezigdomide-dexamethasone doublet

08 Dec 2023 byAudrey Abella

In a study evaluating heavily pretreated patients with relapsed and refractory multiple myeloma (R/R MM), the combination of mezigdomide and dexamethasone showed promising preliminary efficacy, with myelosuppression and infection as primary toxicities.

08 Dec 2023